$250.3M in CY2024 Part D spend524K claims · 158K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Netarsudil used for?
RHOPRESSA is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Is there a generic for Netarsudil?
No. Netarsudil is brand-only with no generic equivalents currently in market.
How much does my plan pay for Netarsudil?
Across 329 Part D plans, Netarsudil averages $131.92/unit (NADAC). Lowest available: $131.92/unit. Highest in distribution: $131.92/unit.
Is Netarsudil on the FDA shortage list?
No. Netarsudil is not currently on the FDA Drug Shortage Database.
6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (1 approvals on file) · NADAC unit costs: CMS NADAC weekly file (1 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.